Experience Our Expertise

Eurofins BioPharma Product Testing offers phase-appropriate GMP Testing Services for the Bio/Pharmaceutical industry, including all starting materials, process intermediates, drug substances, drug product, packaging, and manufacturing support through our broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry and Microbiology.

In Our World, Global Is Local

With a global capacity of more than 2,200,000 square feet of facilities and over 50 locations worldwide, our network of GMP laboratories and vast experience allow us to support projects of any size from early phase through commercialization, including antibody drug conjugates, oligonucleotides, mRNA, cell therapies, gene therapies, monoclonal antibodies, peptides, therapeutic proteins, oncolytic viruses, small molecules, and ophthalmics.

Our local presence with 15 key sites in North America, including PA, IN, MI, MO, NC, NJ, FL, CA, and Toronto, ensures personal service backed by a unique global breadth of harmonized capabilities that supports all functional areas of bio/pharmaceutical drug development.

Collaboration Drives Cost-Effectiveness

Our fundamental philosophy is to help clients efficiently allocate their research and manufacturing expenditures by strategically engaging them to meet their unique outsourcing needs.

We offer the ability to manage your testing programs more efficiently through your choice of three unique service models, including our award-winning PSS Insourcing Solutions^®, Full Time Equivalent (FTE) or traditional fee-for-service.  You can choose the best, most cost-effective service solution for your project goals. 

One CTO. One comprehensive suite of services. One Project Management team eager to make outsourcing simple. Access the leader in consultative problem-solving and world-class testing capabilities.

ABOUT EUROFINS CDMO ALPHORA

Eurofins CDMO Alphora Inc. provides integrated solutions for small molecules, drug product, biologics. Specializing in complex and niche small molecule drug substance and drug product services, including high potent capabilities, we provide support from preclinical to commercial development and manufacturing. Additionally, we specialize in producing pharmaceutical-grade, high-quality phytocannabinoids via synthetic routes and reference standards.

For biologics, our expertise lies in the development and scaling of monoclonal antibodies (mAbs) and other mammalian-based therapeutic proteins. Our offerings include upstream & downstream development, analytical services, antibody drug conjugate (ADC) capabilities, and scale-up capacity to 200L for pre-clinical and phase I supply.

Integrated Services Under One Roof:

Our CDMO site provides tailored solutions underpinned by a strong quality and project management system to ensure efficient pathways to market through expertise in these modalities.

• Small Molecule Drug Substance:
  • Route Scouting
  • Process Development & Optimization
  • GMP Analytical Services
  • Highly Potent APIs
  • GMP, non-GMP Manufacturing
• Small Molecule Drug Product:
  • Pre)-Formulation Development
  • Analytical Services
  • Jet Milling, Nano-milling
  • Oral Solid Dose
  • GMP Clinical Manufacturing
  • Highly Potent Capabilities
• Biologics:
  • Upstream Processing & Development
  • Downstream Processing & Development
  • Analytical Services
  • Process Design & Scale-up
  • Manufacturing
  • Antibody Drug Conjugates
• Solid State R&D:
  • Physicochemical Characterization
  • (Co)-Salt Screening
  • Crystallization Engineering
  • Solubility Enhancement